We are live on
!
Find out more
EARNEST Partners Portfolio holdings
AUM
$24.3B
1-Year Est. Return
34.41%
This Fund
S&P 500
This Quarter
Est. Return
+6.74%
1 Year Est. Return
+34.41%
3 Year Est. Return
+66.51%
5 Year Est. Return
+86.35%
10 Year Est. Return
+426.93%
AUM
$17.3B
AUM Growth
+$975M
(+6%)
Cap. Flow
+$266M
Cap. Flow
% of AUM
1.54%
Top 10 Holdings %
Top 10 Hldgs %
15.95%
Holding
1,183
New
6
Increased
136
Reduced
85
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Papa John's
PZZA
|
+$73.4M |
| 2 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$39.7M |
| 3 |
Amkor Technology
AMKR
|
+$38.1M |
| 4 |
CONMED
CNMD
|
+$30.3M |
| 5 |
Helen of Troy
HELE
|
+$29.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Molina Healthcare
MOH
|
+$110M |
| 2 |
Sanmina
SANM
|
+$82M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
+$63.2M |
| 4 |
ON Semiconductor
ON
|
+$21.8M |
| 5 |
Progressive
PGR
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.75% |
| 2 | Technology | 20.36% |
| 3 | Financials | 17.84% |
| 4 | Consumer Discretionary | 12.04% |
| 5 | Healthcare | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Visa
V
$684B
| $177K | ﹤0.01% |
783
| – | – |
|
277
Constellation Energy
CEG
$93.8B
| $164K | ﹤0.01% |
2,095
| – | – |
|
278
Mastercard
MA
$506B
| $150K | ﹤0.01% |
413
| – | – |
|
279
Procter & Gamble
PG
$336B
| $146K | ﹤0.01% |
980
| – | – |
|
280
MGP Ingredients
MGPI
$379M
| $145K | ﹤0.01% |
1,500
| – | – |
|
281
Home Depot
HD
$331B
| $144K | ﹤0.01% |
487
| – | – |
|
282
Chevron
CVX
$392B
| $143K | ﹤0.01% |
874
| – | – |
|
|
ZYXI
283
DELISTED
Zynex
ZYXI
| $142K | ﹤0.01% |
11,874
| – | – |
|
284
Exelon
EXC
$46.9B
| $142K | ﹤0.01% |
3,396
| – | – |
|
285
Eli Lilly
LLY
$1.02T
| $137K | ﹤0.01% |
398
| – | – |
|
286
Synchrony
SYF
$24.7B
| $137K | ﹤0.01% |
4,695
| – | – |
|
287
AbbVie
ABBV
$443B
| $135K | ﹤0.01% |
847
| – | – |
|
288
Axos Financial
AX
$5.77B
| $133K | ﹤0.01% |
3,600
| – | – |
|
289
Merck
MRK
$322B
| $126K | ﹤0.01% |
1,183
| – | – |
|
290
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.83B
| $123K | ﹤0.01% |
1,194
-2,705
| -69% | -$289K |
|
291
Lloyds Banking Group
LYG
$89.5B
| $121K | ﹤0.01% |
52,224
| – | – |
|
292
Broadcom
AVGO
$1.85T
| $119K | ﹤0.01% |
1,860
| – | – |
|
293
Coca-Cola
KO
$377B
| $110K | ﹤0.01% |
1,777
| – | – |
|
294
VanEck Vietnam ETF
VNM
$491M
| $109K | ﹤0.01% |
8,922
| – | – |
|
295
Pfizer
PFE
$143B
| $108K | ﹤0.01% |
2,641
| – | – |
|
296
Salesforce
CRM
$151B
| $107K | ﹤0.01% |
536
| – | – |
|
297
Cisco
CSCO
$457B
| $106K | ﹤0.01% |
2,032
| – | – |
|
298
iShares MSCI India ETF
INDA
$6.89B
| $105K | ﹤0.01% |
2,679
| – | – |
|
299
PepsiCo
PEP
$190B
| $104K | ﹤0.01% |
569
| – | – |
|
300
Thermo Fisher Scientific
TMO
$213B
| $103K | ﹤0.01% |
178
| – | – |
|
Similar funds
JG
SC
CS
AF
EARNEST Partners's Q1 2023 Portfolio in Review
As of Q1 2023, EARNEST Partners held 1,183 positions worth $17.3B, up 6% from $16.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 1.4%. EARNEST Partners opened 6 new positions and exited 11, leaving the 1,183-position portfolio largely intact.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 21% a quarter earlier, followed by Technology and Financials.
- EARNEST Partners's largest Q1 2023 buy was Papa John's: 866,230 shares worth $64.9M.
- EARNEST Partners added most to Syneos Health, Inc. Class A Common Stock in Q1 2023, an estimated $39.7M increase.
- EARNEST Partners's biggest Q1 2023 reduction was Molina Healthcare, cutting an estimated $110M.
- EARNEST Partners fully exited Vanguard Morningstar Mid-Cap ETF in Q1 2023, selling an estimated $280K.
- EARNEST Partners's ten largest holdings make up 16% of its $17.3B portfolio in Q1 2023.
- EARNEST Partners opened 6 new positions and closed 11 in Q1 2023.
- EARNEST Partners's portfolio value rose 6% quarter-over-quarter to $17.3B.
Based on EARNEST Partners's 13F filing for Q1 2023, filed 15 May 2023.